Multiple studies have reported that the telomerase reverse transcriptase promoter (TERTp) is the most common clonally activating mutation in glioblastoma multiforme (GBM), maintaining telomere length through the overexpression of telomerase reverse transcriptase (TERT) to achieve genomic stability in tumor cells.21 The gene discussed is TERT; the disease is glioblastoma.